Stockscreener 앱 받기
1.285
5.33%
0.065
전일 마감가:
$1.22
열려 있는:
$1.24
하루 거래량:
313.97K
Relative Volume:
0.19
시가총액:
$88.00M
수익:
$129.87M
순이익/손실:
$-44.09M
주가수익비율:
-1.5576
EPS:
-0.825
순현금흐름:
$-30.55M
1주 성능:
-3.38%
1개월 성능:
-28.61%
6개월 성능:
-62.86%
1년 성능:
-71.70%
1일 변동 폭
$1.23
$1.31
1주일 범위
$1.201
$1.455
52주 변동 폭
$1.17
$5.34
Neuronetics Inc Stock (STIM) Company Profile
명칭
Neuronetics Inc
전화
877-600-7555
주소
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.285 | 83.55M | 129.87M | -44.09M | -30.55M | -0.825 |
|
ABT
Abbott Laboratories
|
110.51 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
345.81 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.22 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.21 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.73 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2018-07-24 | 개시 | Canaccord Genuity | Buy |
모두보기
Neuronetics Inc 주식(STIM)의 최신 뉴스
Neuronetics, Inc. Hits New 52-Week Low at $1.19 Amid Declining Stock Performance - Markets Mojo
Neuronetics to Report Fourth Quarter 2025 Results March 17 - MyChesCo
Can Neuronetics Inc. stock sustain free cash flow growth2025 Geopolitical Influence & Verified Technical Trade Signals - Naître et grandir
Aug Momentum: Can Neuronetics Inc outperform in the next rallyBuy Signal & Weekly High Potential Stock Alerts - baoquankhu1.vn
Volatility Watch: Why is Neuronetics Inc stock going upMarket Trend Review & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
STIM (NASDAQ: STIM) insider notifies sales; Macan sold 20,?32 shares - Stock Titan
Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call - Yahoo Finance
Neuronetics Amends Registration Rights, Aligns With Major Shareholder - TipRanks
Neuronetics (STIM) revises Madryn registration rights and adds 2026 voting pact - Stock Titan
Aug Catalysts: Why is Neuronetics Inc stock going upDollar Strength & Real-Time Sentiment Analysis - baoquankhu1.vn
STIM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Neuronetics (NASDAQ:STIM) CEO Keith Sullivan Sells 8,452 Shares - MarketBeat
Macan, Neuronetics EVP, CLO and CS, sells $4.6k in STIM stock - Investing.com
Neuronetics (STIM) EVP sells 3,427 shares in tax withholding trade - Stock Titan
Neuronetics (STIM) CEO sells 8,452 shares to cover RSU tax - Stock Titan
Keith Sullivan sells shares; STIM Form 144 lists 8,452 shares (STIM) - Stock Titan
STIM (NASDAQ: STIM) files Form 144 to sell 3,427 vested common shares - Stock Titan
Neuronetics, Inc. (STIM) Stock Analysis: A Compelling 385% Upside Potential Awaits Investors - DirectorsTalk Interviews
STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024 - TradingView
Neuronetics Grants 2025 Performance-Based Bonuses to Executives - TipRanks
Neuronetics board approves annual cash incentive awards for top executives - Investing.com Nigeria
Neuronetics board approves annual cash incentive awards for top executives By Investing.com - Investing.com Australia
Neuronetics (STIM) approves 2026 annual cash incentives for CEO and top executives - Stock Titan
Neuronetics (NASDAQ: STIM) grants 250,000 RSUs to its CFO - Stock Titan
Peering Into Neuronetics Inc's Recent Short Interest - Benzinga
Neuronetics (STIM) to Release Earnings on Tuesday - MarketBeat
Neuronetics CEO Sullivan sells $55,847 in shares By Investing.com - Investing.com Australia
Neuronetics, Inc. (NASDAQ:STIM) Short Interest Update - Defense World
Neuronetics CEO Sullivan sells $55,847 in shares - Investing.com UK
Neuronetics (NASDAQ:STIM) CEO Keith Sullivan Sells 33,847 Shares of Stock - MarketBeat
Malvern-Based Neuronetics Reports Preliminary 2025 Revenue Growth and Positive Cash Flow - MyChesCo
Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN
Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates - MSN
What’s the RSI of Neuronetics Inc. stockShare Buyback & Real-Time Volume Surge Alerts - mfd.ru
Neuronetics (STIM) Is Down 9.0% After Turning Cash-Flow Positive On NeuroStar Demand Has The Bull Case Changed? - Sahm
Assessing Neuronetics (STIM) Valuation After Positive Cash Flow And Strong Preliminary Q4 Revenue - Yahoo Finance
How cyclical is Neuronetics Inc.’s revenue streamJuly 2025 Decliners & AI Driven Price Forecasts - mfd.ru
Can Neuronetics Inc. outperform in the next rallyMarket Activity Recap & Safe Entry Trade Signal Reports - mfd.ru
Keith Sullivan Sells 40,976 Shares of Neuronetics (NASDAQ:STIM) Stock - MarketBeat
STIM (NASDAQ: STIM) holder Keith Sullivan plans 33,847-share sale - Stock Titan
Neuronetics Beats Expectations with Strong Q4 Revenue and Cash Flow - timothysykes.com
Neuronetics Expects Q4 Revenue To Increase 86%; Stock Up - Nasdaq
Neuronetics reports 86% revenue growth in Q4 2025 By Investing.com - Investing.com Canada
Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On? - Benzinga
STIM Closes 2025 with Strong Cash Position of $34.1 Million - GuruFocus
Neuronetics (STIM) Reports Positive Cash Flow Amid Strong Demand - GuruFocus
Neuronetics Reports Preliminary Fiscal Q4, 2025 Results - marketscreener.com
Neuronetics reports 86% revenue growth in Q4 2025 - Investing.com
Neuronetics, Inc. Reports Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025, Highlighting Significant Revenue Growth - Quiver Quantitative
Neuronetics lifts 2025 revenue 99%, books positive Q4 operating cash flow - Stock Titan
Neuronetics Inc (STIM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.25%
1.00%
자본화:
|
볼륨(24시간):